Clover Health
CLOVMarket price data through November 12, 2026.
Performance
Nov 2021 – Nov 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- +20%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$4
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- October 2024
- The month this stock first became a Benson pick.
- Tracking duration
- 24 months
- How long Benson has been tracking this pick.
About Clover Health
Clover Health sells Medicare Advantage plans, the private health plans seniors can choose instead of original Medicare. It also runs its own software, Clover Assistant, which helps doctors catch health problems early. Think of it as an insurance company that acts like a tech company built for people 65 and older, and nearly all of its 759 million dollars in quarterly revenue comes from those insurance plans.
The case for and against
Both sides of the story, in plain English.
- Profitable Growth Spurt
Revenue hit 759 million dollars this quarter, up 53 percent from a year ago, and Clover now covers 45 percent more seniors. It also made a 6 million dollar profit, after losing 24 million dollars in the same quarter last year. Management raised its full year targets and now expects about 3 billion dollars in sales and the first full year of profit in the company's history.
- Five Star Status
About 98 percent of Clover's members are in its main plan, which just earned Medicare's top 5 Star rating for 2028. Top ratings usually bring extra bonus money from the government and make a plan easier to sell. Clover gives credit to its Clover Assistant software, and it has led the nation on quality of care scores three years in a row.
- Fourth Quarter Dip
Clover has already earned 62 million dollars this year, but its target for the full year is only 25 to 35 million dollars in profit. That math means the company expects to lose roughly 27 to 37 million dollars in the last three months of 2026, a stretch when medical bills and spending to sign up new members usually run higher. A profit story that slips back into losses, even briefly, can rattle the stock.
- Wild Ride
This quarter Clover spent about 91 cents of every insurance dollar on members' medical care, which left less than a penny of profit per dollar of revenue. With so little cushion, a small rise in medical costs can wipe out earnings. The stock also tends to swing about two and a half times as hard as the overall market, in both directions.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-11-12. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch CLOV for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.
